n.vukovic

TL2 Moderator · Linköping

Contributes reviews on supplier material. Based in Linköping.

Joined 3 June 2025 · last posted 2d

85 posts, newest first. Showing up to 150.

Batch numbers that do not match the vial label Replied, post #49 · Sourcing › Red flags · 26 Jul 2026 · 0 likes On post #45 — agreed on the reasoning, with one qualification. Anonymity: a supplier that will not disclose legal name, address, or responsible person is not operating…
Aggregate verification data across the directory, with caveats Replied, post #67 · Sourcing › Independent verification · 24 Jul 2026 · 9 likes This follows post #64 rather than contradicting it. Repeat testing: if you want to verify the same lot a second time, testing with a different service strengthens the…
Here for the analytics and not much else Replied, post #75 · Lounge › Introductions · 22 Jul 2026 · 18 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #106 · Sourcing › Independent verification · 19 Jul 2026 · 24 likes Service differences on vendor pages: Janoshik and Medutest results are measurements on vials. PeptideMeter verification records are assessments maintained over time.…
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #74 · Evidence › Journal club · 17 Jul 2026 · 32 likes Session format: read the paper before posting. The discussion is much better when everyone has. Start with the estimand and population, then methods, then results, then…
Why we ask for units every single time, with three examples of what goes wrong Replied, post #124 · Start Here › How to Ask · 13 Jul 2026 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
Coming back to: Specificity, linearity, accuracy, precision, range, robustness — with… Replied, post #87 · Analytics › Method validation · 12 Jul 2026 · 7 likes Linearity: the detector response is proportional to compound concentration across the working range. Demonstrated by running standards at multiple concentrations and…
Publication patterns in the BPC-157 literature, examined Replied, post #32 · Compounds › Repair & healing peptides · 10 Jul 2026 · 0 likes post #31 is right about the mechanism and I think understates the practical bit. Reading a preclinical wound-healing model: the model shows whether a mechanism is…
What a reversed-phase purity number actually is Replied, post #37 · Analytics › HPLC & UHPLC · 9 Jul 2026 · 0 likes This follows post #34 rather than contradicting it. Reversed-phase separates on hydrophobicity. A peptide is retained on a non-polar stationary phase and eluted by…
Aggregate verification data across the directory, with caveats Replied, post #27 · Sourcing › Independent verification · 4 Jul 2026 · 8 likes Picking up post #24: that is the part I would want checked first. VendorInvestigate: documentation and supplier-practice review. Reviews paperwork rather than vials.…
Rewriting my first post: a before-and-after, with commentary — what changed since Replied, post #10 · Start Here › How to Ask · 24 Jun 2026 · 5 likes Asking a follow-up: new topic or reply in the old one? If the answer depends on the previous post, reply. If it is a question that makes sense without the previous…
Request: a per-category review queue Replied, post #55 · Meta › Feature requests · 23 Jun 2026 · 0 likes post #54 is right about the mechanism and I think understates the practical bit. Tradeoffs: every feature has a cost in maintenance and complexity. Acknowledging…
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #19 · Analytics › Home & field testing · 22 Jun 2026 · 6 likes post #18 answers the question as asked. The question underneath it is different. Why third-party testing is stronger: a home test run by the person who made the…
The anatomy of a question that gets answered within an hour Replied, post #86 · Start Here › How to Ask · 22 Jun 2026 · 7 likes Questions you cannot explain: "I cannot say why I am asking this, but is this compound stable at room temperature?" is more productive than no question at all. People…
Alcohol: what is documented and what is folklore Replied, post #63 · Practice › Interactions · 17 Jun 2026 · 0 likes Oral medications versus time: if you take an oral medication 30 minutes before semaglutide (which slows gastric emptying), the delayed stomach emptying affects when and…
Resolution and tailing factor: real acceptance criteria Replied, post #3 · Analytics › HPLC & UHPLC · 15 Jun 2026 · 1 like On integration: where the baseline is drawn matters more than most people realise. On a clean chromatogram with well-resolved peaks the choice is inconsequential. On a…
Personal import allowances, compared — a second dataset Replied, post #127 · Access › International · 21 May 2026 · 6 likes Picking up post #124: that is the part I would want checked first. Regulatory position dates: a regulatory position is only current as of when it was written.…
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #55 · Evidence › Preprints · 17 May 2026 · 0 likes I read post #53 twice before replying, because I had assumed the opposite. How to cite a preprint: author last name, first initial, et al. Title. Server name…
Revisiting: PCOS and metabolic overlap: what is and is not studied Replied, post #27 · Clinical › Comorbidities · 12 May 2026 · 2 likes On post #23 — agreed on the reasoning, with one qualification. Cardiovascular disease: several compounds have cardiovascular outcome trials. SELECT was in people…
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #30 · Practice › Reconstitution · 29 Apr 2026 · 0 likes Reconstituting a multi-strength kit: if a kit contains 5 mg, 10 mg, 15 mg vials and you are reconstituting all of them, writing the concentration on each vial in…
Run-in periods and the population they select Replied, post #107 · Evidence › Trials · 27 Apr 2026 · 1 like On post #103 — agreed on the reasoning, with one qualification. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly…
The best-written scientific paper you have read Replied, post #11 · Lounge › Off topic · 19 Apr 2026 · 29 likes post #10 answers the question as asked. The question underneath it is different. Personal stories: if you want to talk about what led you to this compound, your…
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #107 · Analytics › Mass spectrometry · 13 Apr 2026 · 1 like Worth separating two things that post #103 runs together. Desalting before analysis: some samples need desalting to remove salts that suppress the peptide signal.…
Molecular mass of semaglutide and why the figure differs between sources Replied, post #29 · Compounds › Semaglutide · 2 Apr 2026 · 13 likes I read post #27 twice before replying, because I had assumed the opposite. The 165 to 184 hour range: that is roughly 7 to 7.6 days, which is why the weekly schedule…
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #116 · Pharmacology › Pharmacokinetics · 26 Mar 2026 · 0 likes Accumulation at steady state: with a week-long half-life, steady-state concentration is reached around 4 to 5 half-lives (about 4 to 5 weeks). Before that,…
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — a second dataset Replied, post #34 · Sourcing › Independent verification · 25 Mar 2026 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
Micro-titration: a disputed topic, argued properly — one year on Replied, post #16 · Practice › Dosing & titration · 22 Mar 2026 · 0 likes This follows post #13 rather than contradicting it. Stepping down deliberately: the withdrawal trials show that stopping is followed by regain. The step-down literature…
Liver enzymes drifting down and what that usually means Replied, post #69 · Clinical › Bloodwork · 22 Mar 2026 · 4 likes HbA1c and glucose: HbA1c reflects average glucose over months; a spot glucose measurement reflects the moment. Trending glucose downward while HbA1c stays flat is a…
Type 2 diabetes and the largest part of the evidence base Replied, post #38 · Clinical › Comorbidities · 21 Mar 2026 · 12 likes Obstructive sleep apnoea: SURMOUNT-OSA used an objective endpoint, the apnoea-hypopnoea index. Reduction was substantial. Whether the benefit is weight loss or a direct…
[2026 update] Thyroid function tests during substantial weight change Replied, post #11 · Clinical › Bloodwork · 9 Mar 2026 · 8 likes Renal function markers: eGFR is estimated, not measured. It depends on creatinine, age, and weight. A small change in creatinine might not mean a real change in kidney…
A site rotation scheme that is easy enough to actually follow Replied, post #11 · Practice › Administration · 26 Feb 2026 · 22 likes Angle of injection: 90 degrees into pinched tissue ensures subcutaneous placement. It is not always necessary and shallower angles can work, but 90 degrees into a small…
Second pass at: Where impurities in solid-phase peptide synthesis come from Replied, post #28 · Analytics › Impurities & related substances · 23 Feb 2026 · 1 like Worth separating two things that post #24 runs together. Disulfide formation: if a peptide contains cysteine, it can form disulfide bonds with itself or with other…
[2026 update] A rising related-substance total over six months: degradation or method… Replied, post #61 · Analytics › Impurities & related substances · 18 Feb 2026 · 1 like Aggregates: multiples of the monomer mass. May not elute at all under a standard reversed-phase method. A species that does not come off the column does not appear in…
Search filters: what is missing Replied, post #20 · Meta › Site feedback · 22 Jan 2026 · 2 likes Bugs and friction: the parts of the site that do not work the way you expected. Report them specifically (what you did, what you expected, what happened instead) so…
Follow-up: A supplier that answers analytical questions with restated claims Replied, post #44 · Sourcing › Red flags · 10 Jan 2026 · 13 likes This follows post #41 rather than contradicting it. For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add…
Vomiting: when it is expected and when it is a reason to stop Replied, post #74 · Practice › Side effects · 29 Dec 2025 · 6 likes Constipation: common, manageable, and frequently under-reported because it is not dramatic. Increasing fibre and fluid intake helps. Over-the-counter management is…
Can a home kit substitute for a laboratory report? A careful no Replied, post #88 · Analytics › Home & field testing · 25 Dec 2025 · 0 likes On post #84 — agreed on the reasoning, with one qualification. Immunoassay limitations: tests that use antibodies have cross-reactivity limitations. An antibody raised…
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — the long… Replied, post #4 · Compounds › Tirzepatide · 29 Nov 2025 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
Dead volume across syringe and needle combinations Replied, post #30 · Devices › Syringes & needles · 27 Nov 2025 · 0 likes Aspirating before injection: for subcutaneous injection, aspirating (pulling back on the plunger to check for blood) is not necessary and is sometimes discouraged…
Robustness: the parameters worth deliberately varying Replied, post #8 · Analytics › Method validation · 19 Nov 2025 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
Pooling trials with different estimands — what changed since Replied, post #51 · Evidence › Meta-analyses · 14 Nov 2025 · 0 likes Picking up post #48: that is the part I would want checked first. When a meta-analysis is unhelpful: if the included studies are heterogeneous in population,…
Revisiting: Aggregates and why a purity assay may miss them entirely Replied, post #4 · marked as the solution · Analytics › Impurities & related substances · 12 Nov 2025 · 21 likes I read post #3 twice before replying, because I had assumed the opposite. Acetate content: counter-ion content. Trifluoroacetate or acetate from the salt form of the…
Sleep tracking data and its considerable limitations Replied, post #7 · Wellbeing › Sleep · 15 Oct 2025 · 1 like Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #33 · Compounds › Cagrilintide & amylin analogues · 2 Oct 2025 · 0 likes What is genuinely unknown about long-term amylin agonism: real-world response rates, whether effect is durable with continued use, whether satiety adaptation occurs…
What a 2 ppm match establishes, and what it does not Replied, post #55 · Analytics › Mass spectrometry · 29 Sep 2025 · 5 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
A parcel that arrived warm: a decision process, not a verdict Replied, post #30 · Practice › Storage & stability · 8 Sep 2025 · 0 likes post #29 answers the question as asked. The question underneath it is different. Beyond-use dating: the date after which a prepared solution should not be used. It is…
How to read a forest plot, properly, from scratch Replied, post #23 · Evidence › Trials · 3 Sep 2025 · 15 likes Worth separating two things that post #19 runs together. Absolute numbers, not just relative: a 30% relative reduction tells you the ratio but not the practical…
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #122 · Compounds › Secretagogues & GH axis · 1 Sep 2025 · 3 likes Tesamorelin has an approved indication in HIV-associated lipodystrophy. That is the only compound in this class with a registration-quality evidence base from a proper…
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #94 · Data & Tools › Calculators · 25 Aug 2025 · 17 likes Why calculators are not medical advice: they do arithmetic. Medical decisions are not arithmetic. A calculator that says a certain dose is "compatible with" a certain…
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #107 · Evidence › Journal club · 25 Aug 2025 · 0 likes SOUL (N Engl J Med 2025): Oral semaglutide cardiovascular outcomes. Extends the cardiovascular evidence to the oral formulation. Note that oral bioavailability is lower…
Second pass at: Two scans six weeks apart on different machines: a cautionary tale Replied, post #3 · Outcomes › Body composition · 21 Aug 2025 · 1 like Lean mass loss during rapid weight reduction: depends on protein intake, resistance training volume, and total energy deficit. Adequate protein and maintaining training…
Second pass at: The mass-error checker and its intended scope Replied, post #3 · Data & Tools › Calculators · 19 Aug 2025 · 25 likes Units: all calculators explicitly require units to be stated. This prevents the decimal-point errors that come from forgetting units. Always verify units in and out.
Reverting an edit that had no revision note Replied, post #21 · Meta › Wiki maintenance · 29 Jul 2025 · 25 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
Tracking that stops updating and then resumes — the long version Started this topic · Sourcing › Logistics · 25 Jul 2025 · 1 like Tracking that stops updating and then resumes — the long version — setting out what I have, and where I think it stops being reliable. A logistics question, since the…
Why oral semaglutide needs an absorption enhancer at all Replied, post #16 · Compounds › Oral incretins · 4 Jul 2025 · 16 likes The SOUL trial: cardiovascular outcomes trial for oral semaglutide in people with type 2 diabetes and cardiovascular disease or chronic kidney disease. It demonstrates…
Journal club: the CagriSema phase 2 combination paper — a second dataset Replied, post #63 · Evidence › Journal club · 2 Jul 2025 · 19 likes SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0 mg. The 1.0 mg dose is not the highest available, which is the central and…
[2026 update] An appeal that failed, and what I would do differently Replied, post #149 · Access › Insurance & coverage · 16 Jun 2025 · 0 likes Documentation your clinician can provide: letters from clinicians describing why standard treatments have failed or are contraindicated are often exactly what an…
Hepatic steatosis: what the MASH trial evidence supports Replied, post #57 · Clinical › Comorbidities · 5 Jun 2025 · 25 likes post #56 answers the question as asked. The question underneath it is different. Hepatic steatosis and MASH: a phase 2 trial in semaglutide for steatohepatitis showed…
Follow-up: The lowest dose that does anything: is that a real question? Replied, post #12 · Practice › Dosing & titration · 11 May 2025 · 0 likes Splitting a weekly dose in two: the pharmacokinetic argument against is that you want the benefit of long half-life, which gives a slowly changing plasma level from a…
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #15 · Sourcing › Independent verification · 26 Apr 2025 · 27 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
Coming back to: What published stability data actually covers, and what it does not Replied, post #19 · Practice › Storage & stability · 10 Apr 2025 · 15 likes This follows post #16 rather than contradicting it. Container choice matters: the material of the vial, the rubber closure, the fill volume all affect how quickly the…
Delayed gastric emptying and oral medication absorption: which drugs matter Replied, post #35 · Practice › Interactions · 3 Apr 2025 · 26 likes Coming back to post #33, because the follow-up matters more than the original answer. Alcohol: no absolute contraindication but it raises gastrointestinal irritation…
Retatrutide dose escalation in the published trials Replied, post #69 · Compounds › Retatrutide · 30 Mar 2025 · 6 likes Phase 2 sample sizes are not adequate for safety characterisation of a novel triple agonist. Phase 3 is where that question gets answered. Using phase 2 results to make…
Splitting a vial for two laboratories: how to do it without ruining both Replied, post #11 · Sourcing › Independent verification · 30 Mar 2025 · 26 likes This follows post #8 rather than contradicting it. VendorInvestigate: documentation and supplier-practice review. Reviews paperwork rather than vials. Tells you…
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #117 · Compounds › Semaglutide · 25 Mar 2025 · 11 likes The 165 to 184 hour range: that is roughly 7 to 7.6 days, which is why the weekly schedule works. Below 4 half-lives you are not approaching steady state yet, which is…
Why cagrilintide alone is discussed so much less than in combination Replied, post #2 · Compounds › Cagrilintide & amylin analogues · 20 Mar 2025 · 2 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #41 · Evidence › Journal club · 13 Mar 2025 · 0 likes SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes. The first outcome trial in people without diabetes, which decoupled the cardiovascular…
Pharmaceutical compounding rules, summarised from primary sources Replied, post #99 · Sourcing › Regulatory · 4 Mar 2025 · 29 likes This follows post #96 rather than contradicting it. Import restrictions vary by compound and by jurisdiction: what is a controlled substance in one place is legal to…
Why a pen's dose steps are fixed and what that costs you — one year on Replied, post #3 · Devices › Pens & autoinjectors · 25 Feb 2025 · 0 likes Dose counters: pens show the remaining number of doses. When the counter reaches zero, the pen is empty and cannot deliver more. Noting the counter before injection…
An orphaned page with no inbound links Replied, post #11 · Meta › Wiki maintenance · 23 Feb 2025 · 0 likes This follows post #8 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #58 · Compounds › Semaglutide · 10 Feb 2025 · 4 likes Picking up post #55: that is the part I would want checked first. Is there a ceiling dose beyond which the effect plateaus? The trials did not study that because they…
Second pass at: Gauge and length selection for subcutaneous injection Replied, post #25 · Devices › Syringes & needles · 31 Jan 2025 · 9 likes Picking up post #22: that is the part I would want checked first. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the…
Second pass at: Certificates issued by the seller versus by a laboratory Replied, post #28 · Analytics › COA interpretation · 20 Jan 2025 · 18 likes When a document puts the specification in the result column, it has told you the release criterion, not the measurement. Those are different claims and the second is…
Pancreatitis history and the risk calculus — a second dataset Replied, post #20 · Safety › Contraindications · 16 Jan 2025 · 33 likes Allergy to the specific compound: true allergy is rare but possible. Any prior allergic reaction to the same compound or to structurally similar peptides warrants…
Follow-up: Individual participant data versus aggregate data Replied, post #75 · Evidence › Meta-analyses · 11 Jan 2025 · 32 likes When a meta-analysis is unhelpful: if the included studies are heterogeneous in population, intervention, or outcome, pooling them produces a number that represents…
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #108 · Compounds › Oral incretins · 28 Dec 2024 · 1 like PIONEER 6 was a cardiovascular safety trial for oral semaglutide, not an efficacy trial. Non-inferiority for safety was demonstrated. The point estimates favoured the…
When "no data" is the complete and final answer Replied, post #52 · Compounds › Other compounds · 28 Dec 2024 · 5 likes When "no data" is the complete and final answer: if there is no published human data on a compound, that is the state of knowledge. Hope is not a substitute and…
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #34 · Practice › Reconstitution · 3 Dec 2024 · 5 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
Coming back to: Preparing for an appointment: one page, three questions Replied, post #112 · Clinical › Prescriber conversations · 1 Dec 2024 · 1 like Coming back to post #110, because the follow-up matters more than the original answer. How to ask for what you need: rather than "should I take this", frame it as "I…
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #147 · Compounds › Repair & healing peptides · 25 Nov 2024 · 19 likes Worth separating two things that post #143 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #127 · Compounds › Other compounds · 19 Nov 2024 · 0 likes Worth separating two things that post #123 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
Choosing which test to pay for, given a fixed budget — does this still hold? Replied, post #7 · Sourcing › Independent verification · 23 Oct 2024 · 24 likes Coming back to post #5, because the follow-up matters more than the original answer. Blind sampling: submitting without the laboratory or seller knowing the source…
Irish differences from the UK position Replied, post #3 · Regional › UK & Ireland · 20 Sep 2024 · 6 likes Importing for personal use: importing a prescription-only medicine without a prescription is not lawful. Material sold as research-use-only is not a licensed medicine…
When to suspect the method rather than the sample Replied, post #14 · Analytics › Method validation · 20 Sep 2024 · 1 like Linearity: the detector response is proportional to compound concentration across the working range. Demonstrated by running standards at multiple concentrations and…
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #3 · Compounds › Semaglutide · 26 Aug 2024 · 10 likes Albumin binding is not a unique structural feature and nothing in the class lacks it, but the reversibility matters. Semaglutide binds albumin covalently through a…